Pulmonx Corporation (LUNG)
NASDAQ: LUNG · Real-Time Price · USD
2.750
+0.190 (7.42%)
Nov 9, 2026, 3:29 PM EST - Market open

Pulmonx Revenue

Pulmonx had revenue of $22.84M in the quarter ending September 30, 2026, with 6.20% growth. This brings the company's total for the last twelve months to $88.78M, down -3.15% year-over-year. In the year 2025, Pulmonx had annual revenue of $90.50M with 8.01% growth. That makes Pulmonx the 23,609th largest company in the world by revenue and 3,372nd in the United States.

Revenue (ttm)
$88.78M
Revenue Growth
-3.15%
P/S Ratio
1.36
Revenue / Employee
$299,916
Employees
296
Market Cap
119.76M

Revenue Chart

Revenue by Geography

  • United States 57.02M 63.0%
  • Europe, Middle-East and Africa (EMEA) 26.99M 29.8%
  • Asia Pacific 6.23M 6.9%
  • Other International 260.00K 0.3%
Fiscal year ended Dec 31, 2025 See the full Pulmonx breakdown

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202590.50M6.71M8.01%
Dec 31, 202483.79M15.11M22.01%
Dec 31, 202368.68M15.01M27.98%
Dec 31, 202253.66M5.25M10.84%
Dec 31, 202148.42M15.68M47.91%
Dec 31, 202032.73M138.00K0.42%
Dec 31, 201932.60M12.59M62.94%
Dec 31, 201820.00M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
Inogen355.06M
Quanterix153.41M
Outset Medical121.97M
Owlet114.41M
Apyx Medical59.57M
Nyxoah32.77M
MaxCyte31.05M
Hyperfine16.54M
Revenue Rankings